Lyka Labs Limited (BOM:500259)
71.42
+0.18 (0.25%)
At close: Feb 4, 2026
Lyka Labs Market Cap
Lyka Labs has a market cap or net worth of 2.55 billion as of February 5, 2026. Its market cap has decreased by -54.71% in one year.
Market Cap
2.55B
Enterprise Value
2.86B
Revenue
1.30B
Ranking
n/a
PE Ratio
n/a
Stock Price
71.42
Market Cap Chart
Since October 1, 2003, Lyka Labs's market cap has increased from 294.62M to 2.55B, an increase of 765.77%. That is a compound annual growth rate of 10.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 5, 2026 | 2.55B | -5.82% |
| Dec 31, 2025 | 2.71B | -51.91% |
| Dec 31, 2024 | 5.63B | 37.55% |
| Dec 29, 2023 | 4.09B | 10.05% |
| Dec 30, 2022 | 3.72B | -41.66% |
| Dec 31, 2021 | 6.38B | 617.10% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Amanta Healthcare | 3.70B |
| ZIM Laboratories | 3.52B |
| Trident Lifeline | 3.46B |
| Kerala Ayurveda | 2.93B |
| Gennex Laboratories | 2.80B |
| Sat Kartar Shopping | 2.31B |
| Oxygenta Pharmaceutical | 2.26B |
| BDH Industries | 2.14B |